Publications
Specialty
Search
Neurology
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
Pharmacy Learning Network
10/22/2024
True or False: Among patients with MS, amyloid plaque accumulation in the brain was more likely in those with a typical MS history.
EP Lab Digest
10/22/2024
Catheter Precision Press Release
FORT MILL, SC / October 21, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced a new publication in the October 2024 issue of HeartRhythm Case Reports.
Podiatry Today
10/22/2024
Podiatry Today spoke to Melissa Lockwood, DPM, FASPS, FACPM, on her recent American Society of Podiatric Surgeons’ (ASPS) Annual Conference presentation.
EMSWorld
10/22/2024
The Missouri EMS Association is collaborating with the Kansas EMS Association, Mid-America Regional Council, Community Asset Builders, and United Methodist Health Ministry Fund to implement MIH networks in six communities across Missouri and Kansas.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/21/2024
MedAxiom has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the largest number of programs since its debut. The report features a foreword from MedAxiom President and CEO Jerry Blackwell, MD, MBA, FACC, on the post-pandemic changes to the provider market through shifting practice ownership models, provider compensation and production trends, and the growing importance of team-based care.
Advances in Inflammatory Bowel Disease Network
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Oncology
10/21/2024
Alexey Danilov, MD, reviews the latest exciting developments in the chronic lymphocytic leukemia clinical research landscape, highlighting BTK and BCL2 inhibitors as well as BTK degraders.
Oncology, Lymphoma, Leukemia & Myeloma Network
10/21/2024
At the 2024 Lymphoma, Leukemia & Myeloma Congress, Alexey Danilov, MD, participated in a debate of optimal frontline therapies for patients with chronic lymphocytic leukemia in which he argued in favor of utilizing acalabrutinib.
Journal of Clinical Pathways
10/21/2024
Pembrolizumab combined with adjuvant carboplatin-paclitaxel significantly improves disease-free survival in patients with high-risk mismatch repair-deficient endometrial cancer, according to a study published in the Journal of Clinical Oncology.
Neurology
10/21/2024
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
EP Lab Digest
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment for even the most complex procedures.
Oncology
10/21/2024
Benjamin Besse, MD, PhD, discusses early analysis results from the MARIPOSA study which demonstrated that amivantamab plus lazertinib has promising antitumor activity in patients with advanced EGFR-mutated NSCLC.
Oncology
10/21/2024
A novel EGFR x HER3 bispecific ADC showed encouraging antitumor activity for heavily-pretreated advanced urothelial carcinoma.
Oncology
10/21/2024
According to second interim data from the MARIPOSA-2 trial, amivantamab plus chemotherapy numerically improved the overall survival, and significantly prolonged the post-progression outcomes among patients with EGFR-mutant non-small cell lung cancer.
Pharmacy Learning Network
10/21/2024
In late September 2024, the Federal Trade Commission brought action against Caremark, Express Scripts, and OptumRx, the 3 largest pharmacy benefit managers and their respective group purchasing agents.
Vascular Disease Management, Journal of Invasive Cardiology
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment for even the most complex procedures.
The Philips Engagement Hub in Hall C at the Walter E. Washington Convention Center will feature numerous physician-led discussions, and hands-on trainings that address a range of key challenges in cardiology.
Vascular Disease Management, Journal of Invasive Cardiology
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death
Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome (ACS)
Supports trend in individualized antiplatelet therapy
PHILADELPHIA, October 21, 2024 (Newswire.com) - Prolocor, Inc., a healthcare startup developing the innovative diagnostic Prolocor pFCG® test that identifies patients at higher and lower risk of thrombotic events (heart attack, stroke, and death), announced today the publication of res
First Report Managed Care
10/21/2024
A study published in the International Journal of Obesity found that gastric bypass surgery leads to significant long-term weight loss and metabolic changes, suggesting that maintaining fat-free mass may help sustain metabolic rates post-surgery.